Champions Oncology
CSBR
12 hedge funds and large institutions have $18.3M invested in Champions Oncology in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
20% more funds holding
Funds holding: 10 → 12 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less capital invested
Capital invested by funds: $26.2M → $18.3M (-$7.84M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$525K |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$478K |
| 3 |
SSB
Sandy Spring Bank
Olney,
Maryland
|
+$35.8K |
| 4 |
JP Morgan Chase
New York
|
+$2.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Alexandria Capital
Arlington,
Virginia
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BPI
1
Battery Partners IX
Boston,
Massachusetts
| $6.97M | – | – | – |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $5.58M | – | – | – |
|
|
PCM
3
PAR Capital Management
Boston,
Massachusetts
| $2.98M | – | – | – |
|
|
PA
4
Perceptive Advisors
New York
| $1.33M | – | – | – |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| $1.04M | +$525K | +122,198 | +72% |
|
|
KCM
6
Knoll Capital Management
Miami,
Florida
| $397K | +$478K | +111,111 | New |
|
|
SSB
7
Sandy Spring Bank
Olney,
Maryland
| $30K | +$35.8K | +8,333 | New |
|
8
Morgan Stanley
New York
| $10K | +$1.12K | +261 | +10% |
|
9
Bank of America
Charlotte,
North Carolina
| $7K | +$4 | +1 | +0% |
|
|
10
UBS Group
Zurich,
Switzerland
| $3K | +$1.3K | +303 | +63% |
|
|
11
JP Morgan Chase
New York
| $2K | +$2.9K | +675 | New |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $1K | +$658 | +153 | +326% |
|
|
AC
13
Alexandria Capital
Arlington,
Virginia
| – | -$6K | -1,188 | Closed |
|
CSBR Hedge Fund Activity: Q4 2015 in Review
12 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q4 2015, worth a combined $18.3M — down 30% from $26.2M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CSBR positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $525K. The largest seller was Alexandria Capital, exiting entirely with an estimated $6K sold.
- 12 institutional investors held Champions Oncology (CSBR) as of Q4 2015, up from 10 in Q3 2015.
- Funds reported $18.3M of Champions Oncology stock for Q4 2015, down 30% quarter-over-quarter.
- 3 funds opened new Champions Oncology positions in Q4 2015 and 1 closed out, a net change of +2 holders.
- The largest Champions Oncology buyer in Q4 2015 was Sabby Management, an estimated $525K added.
- The largest Champions Oncology seller in Q4 2015 was Alexandria Capital, an estimated $6K sold.
Based on aggregated 13F filings for Q4 2015.